Biolife solutions stock.

Supplier: BIOLIFE SOLUTIONS INC 210373. This item has a minimum qty of 4 per supplier requirements. The CryoStor series of cell-specific, optimized freeze media, is designed to prepare and preserve cells in ultra low temperature environments (-70C to -196C). CryoStor CS10, pre-formulated with 10% DMSO, provides a safe, protective environment ...Discover more Overcome the challenges of cell expansion and product preservation throughout CGT processing. Independent research demonstrates the medium and material used in sample cryopreservation impacts biologic viability. Formulation must be sterile, free from adventitious agents and qualified before use to remove susceptibility from batch-to …BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to break-even earnings per share a year ago.Mar 23, 2023 · BioLife Solutions Reports Third Quarter 2023 Financial Results. BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene... Nov 02, 2023.

The corporate mailing address for Ms. Aebersold and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Sarah Aebersold's contact information.For the upcoming trading day on Monday, 4th we expect BioLife Solutions to open at $12.82, and during the day (based on 14 day Average True Range), to move ...BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 29.17% and 4.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) shares fell 4.2% during trading on Monday . The company traded as low as $13.37 and last traded at $13.49. 76,840 shares changed hands ...Aug 9, 2021 · BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton ... SenseAnywhere: Cloud-based Monitoring Solutions. Users can connect any number of refrigerators, ULT freezers, and cryogenic freezers to view performance data in one SenseAnywhere account. SenseAnywhere is 21 CFR part 11 compliant and EN12830-2018. Users can download temperature records for audit trail purposes and Good …BOTHELL, Wash., Aug. 8, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of class-defining bioproduction tools and services for the cell ...

BLFS BioLife Solutions stock chart. #fintwits #money #wallstreet #stockmarket #stocks. 0 points. 1 comment. 1. 0 comments. share. save. 2. Posted by 2 years ago. I want to buy a trading bot, any recommendations here? 2. 3 comments. share. save. 1. Posted by 2 years ago. Adam Khoo FX trading. Hello! I got some courses a while back and have ...

Mar 22, 2021 · With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted Net Income per share basis (Non-GAAP) in ...

Stock Information. The interactive chart below shows a historical timeline of our stock price and trading volume. Click on the tabs below to view the different timeframes. You may also view data on Dividend, Split, and Earning History by using the Events tab. NASDAQBLFS. 5d. 1m. 3m. 6m.BioLife Solutions GAAP EPS of -$0.17 beats by $0.09, revenue of $36.22M misses by $1.98M SA News Mon, May 09, 2022 BioLife Solutions gains as Oppenheimer upgrades on valuationNov 15, 2023. Currency in USD. Quote data delayed by at least 15 minutes. Earnings and Analyst data provided by Zacks. Insiders data provided by Morningstar. CONTACT.The estimated net worth of Marcus Schulz is at least $465,171.85 as of August 25th, 2023. Mr. Schulz owns 42,097 shares of BioLife Solutions stock worth more than $465,172 as of November 2nd. This net worth approximation does not reflect any other investments that Mr. Schulz may own. Learn More about Marcus Schulz's net worth.Nov 16, 2023 · Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS) is a bioproduction tools and services provider. On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed ...

Mar 13, 2023 · BioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ... Discover historical prices for BLFS stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Solutions, Inc. stock was issued. Mar 22, 2021 · BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ... BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and ...BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of biological materials. BioLife Solutions is one of Washington’s best places to work ...Maximize post-thaw cell recovery and viability following cryopreservation at low temperatures (-80°C to -196°C) with ready-to-use CryoStor® CS5. Serum-free, animal component-free, and cGMP-manufactured, this defined medium provides a safe, protective environment for cells and tissues during freezing and thawing processes and storage.

CryoStor®CS10 effectively mitigates temperature-induced molecular cell stress responses to maximize post-thaw viability and recovery for a variety of immune cell types, including T cells (data not shown) and B cells. Here, human B cells from 6 different donors cryopreserved in CryoStor®CS10 show reproducibly high viability after thawing, as ...

5 Wall Street analysts have issued 1 year target prices for BioLife Solutions' stock. Their BLFS share price targets range from $22.00 to $28.00. On average, they expect the company's stock price to reach $24.60 in the next year. This suggests a possible upside of 91.7% from the stock's current price. View analysts price targets for BLFS or ...Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …BioLife Solutions Stock Performance. BLFS stock opened at $14.08 on Monday. The business has a 50 day moving average of $12.13 and a 200-day moving average of $16.47. BioLife Solutions, Inc. has a 12-month low of $8.92 and a 12-month high of $26.89. The firm has a market cap of $619.96 million, a PE ratio of -5.94 and a beta of 1.57.Todd Berard, BioLife's Chief Marketing Officer, commented, "With a capacity that's 40% larger than other tabletop CRFs, IntelliRate i67C is perfectly sized to efficiently scale precision rate freezing as a customer's capacity needs grow. We designed the IntelliRate i67C to increase single-batch, LN2 CRF capacity from mid- and late-stage …On average, Wall Street analysts predict. that Biolife Solutions's share price could reach $25.50 by Aug 10, 2024. The average Biolife Solutions stock price prediction forecasts a potential upside of 103.84% from the current BLFS share price of $12.51. 2.70% of BioLife Solutions stock is owned by insiders. Learn more on BLFS's insider holdings. Which BioLife Solutions insiders have been buying company stock? The following insider purchased BLFS shares in the last 24 months: Casdin Partners Master Fund, L ($12,648,274.13).

BioLife Solutions, Inc. : News, information and stories for BioLife Solutions, Inc. | Other OTC: | Other OTC

Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

The BioLife Solutions stock price gained 3.76% on the last trading day (Friday, 24th Nov 2023), rising from $13.57 to $14.08. During the last trading day the stock fluctuated 11.10% from a day low at $12.79 to a day high of $14.21. The price has risen in 6 of the last 10 days and is up by 23.62% over the past 2 weeks.BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), …Biolife Solutions (BLFS) stock price prediction is 34.019673488189 USD. The Biolife Solutions stock forecast is 34.019673488189 USD for 2024 November 15, ...Hedge fund activity in BioLife Solutions, Inc. (NASDAQ:BLFS) Heading into the second quarter of 2020, a total of 9 of the hedge funds tracked by Insider Monkey were long this stock, a change of ...BioLife issued 6,646,870 shares of common stock in exchange for 100% of the outstanding shares of Stirling. BioLife management has provided guidance for Stirling's 2021 post-closing revenue contribution to be $35 million to $37 million , with total 2021 revenue of $101 million to $110 million .BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to break-even earnings per share a year ago.Name. Chg %. Market Cap. Evogene Ltd. -1.07%. $30.17M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial... First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ...Get the latest BioLife Solutions Inc (BLFS) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the fiscal Q2 2023 ended 6/30/23. Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ... Press Releases. BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 Adjusted gross margin improvement; 37% compared to 32% in Q4 2022. Decision to Explore Strategic Alternatives for Ultra-Low ...

Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. While BioLife Solutions, Inc. ( NASDAQ:BLFS) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the NASDAQCM, rising to highs ...Instagram:https://instagram. nvidia stock predictions 2025as techname ideas for llcdoes aarp offer dental plans Biolife Solutions Inc stock received a consensus recommendation rating of a Buy, based on a mean score of 1.25. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended BLFS as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, New York 11717 USA (877) 830 - 4936 [email protected] target olaplexshort squeeze stock list Get in touch. BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell , WA 98021 USA. For assistance, please call us Monday through Friday (9:00 am to 5:00 pm PST) at:BioLife Solutions (BLFS) In a report released today, Robert Wasserman from Benchmark Co. maintained a Hold rating on BioLife Solutions. The company’s shares closed last Thursday at $11.96. does rocket mortgage finance manufactured homes BOTHELL, Wash., Sept. 1, 2021 / PRNewswire / -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies ...The business earned $33.33 million during the quarter, compared to the consensus estimate of $33.28 million. BioLife Solutions has generated ($2.37) earnings per share over the last year (($2.37) diluted earnings per share). Earnings for BioLife Solutions are expected to grow in the coming year, from ($1.06) to ($0.26) per share.In today’s fast-paced world, maintaining a healthy lifestyle can be challenging. However, thanks to technological advancements, we now have access to various tools and applications that can help us track our nutritional intake and make info...